Hansoh Pharma Successfully Wins Bids for Five Products in China's 7th National Drug Volume-Based Procurement

Gelonghui July 12th: Today, the seventh round of China's national centralized drug procurement began. According to reports, five high-quality drugs from Hansoh Pharma were successfully selected, namely Hengsen (Micafungin Sodium for Injection), Pulaidi (Erlotinib Hydrochloride Tablets), Afatinib Maleate Tablets, Shengfuda (Sunitinib Malate Capsules), and Lurasidone Hydrochloride Tablets.